Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

This study has been terminated.
(NCT01318642: Planned independent DMC Interim review: ended for futility w/no safety concerns)
Sponsor:
Information provided by (Responsible Party):
Amgen
ClinicalTrials.gov Identifier:
NCT01318642
First received: March 17, 2011
Last updated: August 6, 2014
Last verified: August 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2012
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 29, 2014